Replies to post #27150 on Biotech Values

[spartex]

<I'm guessing this puts another question mark on the "Pfizer will buy YMI" theory.>

So DNDN may still be in the running as a possibility for a Pfizer partnership or acquisition this year? Seems like a reasonable hypothesis from David M's earlier article.